Recently, our CSO Dr. Ya-Chi Chen was featured in an interview with Bioconjugate Insights, where she shared OBI’s approach to next-generation ADC design.

Read more:
obipharma.com/news/bioconj...

#BispecificAntibodies #DualPayloadADC
#ADC #CancerResistance #NextGenADC